Ceramides: A new player in the inflammation-insulin resistance paradigm?

被引：26

作者：

Gill, J. M. R. ^{[1
]}

Sattar, N. ^{[2
]}

机构：

[1] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland

[2] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland

来源：

DIABETOLOGIA | 2009年 / 52卷 / 12期

关键词：

Ceramides; IL-6; Inflammation; Insulin resistance; TNF-alpha; HUMAN SKELETAL-MUSCLE; DIABETES-MELLITUS; SENSITIVITY; PREDICTION; INSIGHTS; RISK;

D O I：

10.1007/s00125-009-1546-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2475 / 2477

页数：3

共 14 条

[1] Ceramide content is increased in skeletal muscle from obese insulin-resistant humans [J].

Adams, JM ;

Pratipanawatr, T ;

Berria, R ;

Wang, E ;

DeFronzo, RA ;

Sullards, MC ;

Mandarino, LJ .

DIABETES, 2004, 53 (01) :25-31

[2] Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease [J].

de Mello, V. D. F. ;

Lankinen, M. ;

Schwab, U. ;

Kolehmainen, M. ;

Lehto, S. ;

Seppanen-Laakso, T. ;

Oresic, M. ;

Pulkkinen, L. ;

Uusitupa, M. ;

Erkkila, A. T. .

DIABETOLOGIA, 2009, 52 (12) :2612-2615

[3] Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance [J].

Haus, Jacob M. ;

Kashyap, Sangeeta R. ;

Kasumov, Takhar ;

Zhang, Renliang ;

Kelly, Karen R. ;

DeFronzo, Ralph. A. ;

Kirwan, John P. .

DIABETES, 2009, 58 (02) :337-343

[4] Sphingolipids, insulin resistance, and metabolic disease:: New insights from in vivo manipulation of sphingolipid metabolism [J].

Holland, William L. ;

Summers, Scott A. .

ENDOCRINE REVIEWS, 2008, 29 (04) :381-402

[5] Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance [J].

Holland, William L. ;

Brozinick, Joseph T. ;

Wang, Li-Ping ;

Hawkins, Eric D. ;

Sargent, Katherine M. ;

Liu, Yanqi ;

Narra, Krishna ;

Hoehn, Kyle L. ;

Knotts, Trina A. ;

Siesky, Angela ;

Nelson, Don H. ;

Karathanasis, Sotirios K. ;

Fontenot, Greg K. ;

Birnbaum, Morris J. ;

Summers, Scott A. .

CELL METABOLISM, 2007, 5 (03) :167-179

[6] Interleukin-1-receptor antagonist in type 2 diabetes mellitus [J].

Larsen, Claus M. ;

Faulenbach, Mirjam ;

Vaag, Allan ;

Volund, Aage ;

Ehses, Jan A. ;

Seifert, Burkhardt ;

Mandrup-Poulsen, Thomas ;

Donath, Marc Y. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (15) :1517-1526

[7] Key role for ceramides in mediating insulin resistance in human muscle cells [J].

Pickersgill, Laura ;

Litherland, Gary J. ;

Greenberg, Andrew S. ;

Walker, Mark ;

Yeaman, Stephen J. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (17) :12583-12589

[8] Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? [J].

Sattar, N. ;

Wannamethee, S. G. ;

Forouhi, N. G. .

DIABETOLOGIA, 2008, 51 (06) :926-940

[9] Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity [J].

Skovbro, M. ;

Baranowski, M. ;

Skov-Jensen, C. ;

Flint, A. ;

Dela, F. ;

Gorski, J. ;

Helge, J. W. .

DIABETOLOGIA, 2008, 51 (07) :1253-1260

[10] Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes [J].

Straczkowski, M. ;

Kowalska, I. ;

Baranowski, M. ;

Nikolajuk, A. ;

Otziomek, E. ;

Zabielski, P. ;

Adamska, A. ;

Blachnio, A. ;

Gorski, J. ;

Gorska, M. .

DIABETOLOGIA, 2007, 50 (11) :2366-2373

← 1 2 →